Literature DB >> 2942077

Predictive value of bronchoalveolar T cell subsets for the course of pulmonary sarcoidosis.

U Costabel, K J Bross, J Guzman, A Nilles, K H Rühle, H Matthys.   

Abstract

To study the value of knowing the proportions of bronchoalveolar T cell subsets when predicting the course of pulmonary sarcoidosis, we subjected 31 patients to clinical, physiologic, and radiographic evaluations, with controls, for at least 12 months. Initially, when all patients were untreated, BAL's were performed, and BAL lymphocyte subsets were marked by the following monoclonal antibodies: OKT3 (expressed by all T cells), OKT4 (to mark helper-inducer T cells), OKT8 (to mark suppressor-cytotoxic T cells), and OKIa (to mark Ia antigen-positive, activated T cells). A normal T4/T8 ratio was highly predictive of a favorable course: the conditions of 13 out of 15 patients with normal ratios remained stable or improved, and only 2 of these 15 patients had to be treated because of persistent symptoms. On the other hand, the conditions of 10 out of 16 patients with elevated T4/T8 ratios deteriorated during the follow-up period. The specificity of T cell subsets for predicting deterioration was improved by considering both the T4/T8 ratio and the number of Ia antigen-positive, activated T cells present. Deterioration occurred in 9 out of 11 patients with elevated T4/T8 ratios and elevated levels of activated T cells. These results suggest that the subtyping of BAL lymphocytes may be useful in determining prognosis in pulmonary sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942077     DOI: 10.1111/j.1749-6632.1986.tb18518.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

Review 1.  Future directions for bronchoalveolar lavage.

Authors:  S I Rennard
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Characteristics and clinical significance of the lymphocytic alveolitis in interstitial lung disorders.

Authors:  G A Rossi; B Balbi; S Lantero; C Ravazzoni
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Analysis of CD4-positive T cell subpopulation in sarcoidosis.

Authors:  R Gerli; S Darwish; L Broccucci; V Minotti; F Spinozzi; C Cernetti; A Bertotto; P Rambotti
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

4.  Bronchoalveolar lavage cell counts as a predictor of short term outcome in pulmonary sarcoidosis.

Authors:  N M Foley; A P Coral; K Tung; B N Hudspith; D G James; N M Johnson
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

5.  Correlation of GM-CSF mRNA in bronchoalveolar fluid with indices of clinical activity in sarcoidosis.

Authors:  A Itoh; E Yamaguchi; K Furuya; N Hizawa; N Ohnuma; Y Kawakami; N Kuzumaki
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

6.  Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation.

Authors:  K Ward; C O'Connor; C Odlum; M X Fitzgerald
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

Review 7.  Enigmas in sarcoidosis.

Authors:  A N Chesnutt
Journal:  West J Med       Date:  1995-06

8.  Predictive value of bronchoalveolar lavage cell analysis in sarcoidosis.

Authors:  L Bjermer; L Rosenhall; T Angström; R Hällgren
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

9.  The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings.

Authors:  Robert Kieszko; Paweł Krawczyk; Tomasz Powrózek; Aneta Szudy-Szczyrek; Michał Szczyrek; Iwona Homa; Jadwiga Daniluk; Janusz Milanowski
Journal:  Arch Med Sci       Date:  2015-04-28       Impact factor: 3.318

Review 10.  Bronchoalveolar lavage.

Authors:  W R Martin; P A Padrid; C E Cross
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.